z-logo
open-access-imgOpen Access
Sympathometabolic profile of a fixed combination of lercanidipine with enalapril in the treatment of obese hypertensive patients (study review)
Author(s) -
П. О. Лазарєв
Publication year - 2021
Publication title -
lìki ukraïni
Language(s) - English
Resource type - Journals
ISSN - 1997-9894
DOI - 10.37987/1997-9894.2021.8(254).245830
Subject(s) - lercanidipine , enalapril , concomitant , medicine , angiotensin converting enzyme , fixed dose combination , combination therapy , cardiology , calcium channel , pharmacology , urology , calcium , blood pressure
The publication highlights the main possibilities of fixed combinations of angiotensin-converting enzyme inhibitors with calcium channel blockers in the treatment of hypertension and the advantages of the combination of enalapril 20 mg / lercanidipine 10 mg in terms of sympathomodulatory properties. Clinical data are provided that indicate the benefit of using this combination in patients with hypertension and concomitant obesity

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here